Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home Topics Infectious Diseases Infections A-Z Escherichia coli ( E. coli ) Mandatory surveillance of Escherichia coli bacteraemia

Mandatory surveillance of Escherichia coli bacteraemia

Public Health England - PHE (formerly the Health Protection Agency) has collected mandatory Escherichia coli data since 2011. Prior to this date voluntary data were collected from laboratory reports.

In June 2011 surveillance of E. coli became mandatory; since then PHE has been managing this mandatory system on behalf of the Department of Health (DH). PHE produces tables of counts of E.coli bacteraemia on a monthly basis. The first annual E.coli bacteraemia will be published July 2013. Every quarter the data collected in the enhanced surveillance is used to produce epidemiological commentaries, with the aim of contributing to a better evidence base regarding risk factors for infection.

Please note as of April 2013 Primary Care Organisations (PCOs) ceased to exist and were replaced by Cinical Commissioning Groups (CCGs). Therefore data published monthly is now reported by CCG rather than PCO. Archive monthly outputs reporting data to the end of March 2013 are still by PCO.

The results of the mandatory Escherichia coli enhanced surveillance scheme:

  • E. coli  bacteraemia tables - Monthly : Acute Trust and Clinical Commissioning Group (CCG) results by month for a 13 month period
  • E. coli  bacteraemia tables- Annual: Acute Trust and Clinical Commissioning Group results by quarter and by financial year. July 2011 onwards.
  • E. coli bacteraemia commentaries - Quarterly: Commentary on trends over a period of 7 quarters.
Background Information

The Department of Health (DH) has asked NHS acute Trusts to report episodes of Escherichia coli bacteraemia to PHE through the established enhanced mandatory surveillance Data Capture System (DCS); with effect from 1 June 2011. This is following a year-on-year increase in Gram-negative bacteraemia as reported by PHE via the voluntary surveillance system and an ARHAI recommendation to commence E. coli bacteraemia surveillance.

The purpose of the enhanced surveillance is to gather information on the phenomenon of increasing reports of Gram-negative bacteraemia and particularly E. coli bacteraemia. This information will allow more accurate determination of possible interventions to prevent avoidable bacteraemias.

Further guidance and answers to frequently asked questions are now available in addition to a reporting form to aid with data collection.


What's new